10 Best Penny Stocks That Could Skyrocket in 2026
In this article, we look at the 10 Best Penny Stocks That Could Skyrocket in 2026. Penny stocks can deliver dramatic gains when a business achieves a milestone that investors had discounted.
Ardelyx Inc. (ARDX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.84 | 333,333 | $1,946,331.39 | 3,302,918 | 2026-02-20 | Filing | |
| $3.63 | 200,000 | $725,880.00 | 2,896,871 | 2025-06-16 | Filing | |
| $3.69 | 200,000 | $737,260.00 | 2,696,871 | 2025-06-09 | Filing | |
| $3.29 | 100,000 | $329,120.00 | 2,496,871 | 2025-05-15 | Filing | |
| $4.22 | 381,377 | $1,610,936.45 | 2,396,871 | 2025-05-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.86 | 1,558 | $6,009.05 | 227,520 | 2026-08-21 | Filing | |
| $3.86 | 1,110 | $4,281.16 | 145,854 | 2026-08-21 | Filing | |
| $3.86 | 2,872 | $11,077.02 | 146,964 | 2026-08-21 | Filing | |
| $3.86 | 2,469 | $9,522.69 | 317,095 | 2026-08-21 | Filing | |
| $3.86 | 17,281 | $66,651.09 | 319,564 | 2026-08-21 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,338,849 | $4,578,864 | 0.13% | |
| 2. | 314,215 | $1,074,615 | 0.5% | |
| 3. | 300,000 | $1,017,000 | 0.01% | |
| 4. | 185,066 | $632,926 | 0.03% | |
| 5. | 119,200 | $407,664 | 0% |
News See All
11 Best 52-Week Low Penny Stocks to Invest In
In this article, we look at the 11 Best 52-Week Low Penny Stocks to Invest In.
Claude AI Says Market is Ignoring Ardelyx (ARDX) Growth Catalysts
Ardelyx, Inc (NASDAQ:ARDX) is a biotech company. It makes drugs for gut and kidney conditions.
10 Best Low Priced Stocks to Get Rich in 2026
In this article, we will take a look at the best low priced stocks to get rich in 2026. These days, everyone is focusing on finding ways to get rich.
Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot
In this article, we will discuss Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot.
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2026 Earnings Call Transcript
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2026 Earnings Call Transcript April 30, 2026Ardelyx, Inc. misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.13.
Ardelyx, Inc. (NASDAQ:ARDX) Q4 2025 Earnings Call Transcript
Ardelyx, Inc. (NASDAQ:ARDX) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Welcome to the Ardelyx Fourth Quarter 2025 Earnings Conference.
Ardelyx, Inc. (ARDX) Reports Strong 2025 Revenue Growth, Updates 2026 Outlook
We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. Ardelyx, Inc.
10 Best Long Term Healthcare Stocks to Buy
In this article, we will discuss 10 Best Long Term Healthcare Stocks to Buy.
Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results
We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. Ardelyx, Inc. is next on our list.
Hedge Fund Resource Center